Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.

Demir S., Soyer Ö. , Bilginer Y., Sag E. , Sahiner Ü. M. , Buyuktiryaki B., ...More

Clinical and experimental rheumatology, vol.38, no.3, pp.552-557, 2020 (Journal Indexed in SCI Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 38 Issue: 3
  • Publication Date: 2020
  • Title of Journal : Clinical and experimental rheumatology
  • Page Numbers: pp.552-557
  • Keywords: biologic drugs, children, hypersensitivity, rituximab, rapid drug desensitisation, tocilizumab, RHEUMATOID-ARTHRITIS, B-CELLS, RAPID DESENSITIZATION, MANAGEMENT, SAFETY, ANAPHYLAXIS, DIAGNOSIS, SCLEROSIS